Legal Representation
Attorney
Emilia F. Cannella
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 10, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 25, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 25, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 30, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 30, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 10, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 21, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 21, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 21, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 22, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 22, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 24, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 24, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 24, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 24, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 27, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 15, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention, inhibition and treatment of gastrointestinal diseases and disorders, autoimmune diseases and disorders, inflammatory diseases and disorders, developmental diseases and disorders, degenerative diseases and disorders, metabolic diseases and disorders, cancer, pain, frailty, inflammation, and infection
Class 042
Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services
Additional Information
Design Mark
The mark consists of three unshaded hexagons connected by straight lines, and three shaded hexagons, one centered at the top of the two connected hexagons, one appearing to the left and one appearing to the right of the connected hexagons.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042